Stone House Investment Management, LLC Intellia Therapeutics, Inc. Transaction History

Stone House Investment Management, LLC

  • $477 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$20.02 - $27.22 $440 - $598
-22 Reduced 29.73%
52 $1,000
Q1 2024

May 15, 2024
SELL
$23.82 - $32.8 $1,857 - $2,558
-78 Reduced 51.32%
74 $2,000
Q4 2023

Jan 30, 2024
BUY
$23.16 - $32.34 $2,316 - $3,234
100 Added 192.31%
152 $4,000
Q1 2023

Apr 25, 2023
BUY
$33.3 - $44.82 $1,731 - $2,330
52 New
52 $1,000

Others Institutions Holding NTLA

# of Institutions
314
Shares Held
91.5M
Call Options Held
442K
Put Options Held
880K
View Full List

About Intellia Therapeutics, Inc.

NTLA Quotes by TradingView
  • Ticker NTLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,011,800
  • Market Cap $775M
  • Description
  • Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...
More about NTLA
Track This Portfolio

Track Stone House Investment Management, LLC Portfolio

Follow Stone House Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stone House Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stone House Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email